On 5/10/24, MacroGenics Inc (NASDAQ: MGNX) stock suffered a major decline of -77.4%, closing at $3.31. Moreover, exceptionally high trading volume at 1592% of normal accompanied the decline. The stock has been exceptionally strong relative to the market over the last nine months but has declined -78.3% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, MGNX is expected to continue to be a major Value Builder.
MacroGenics has a current Value Trend Rating of B (Positive). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. MacroGenics has a neutral Appreciation Score of 49 but a very high Power Rating of 94, resulting in the Positive Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of B. This review will be completed in the next several days.
Be the first to comment